MENU
+Compare
BGLC
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$4.53
Change
-$0.31 (-6.40%)
Capitalization
8.8M

BGLC Bionexus Gene Lab Corp Forecast, Technical & Fundamental Analysis

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region... Show more

BGLC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BGLC with price predictions
Nov 12, 2025

BGLC in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 12, 2025

BGLC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 46 cases where BGLC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where BGLC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BGLC advanced for three days, in of 100 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BGLC as a result. In of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BGLC turned negative on November 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

BGLC moved below its 50-day moving average on November 06, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BGLC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BGLC entered a downward trend on October 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BGLC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.170) is normal, around the industry mean (4.648). P/E Ratio (0.000) is within average values for comparable stocks, (80.682). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.544). BGLC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.032). P/S Ratio (0.922) is also within normal values, averaging (141.392).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGLC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
BGLC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ChemicalsSpecialty

Profile
Fundamentals
Details
Industry
N/A
Address
No. 8 Jalan Kerinchi
Phone
+60 122126512
Employees
15
Web
https://www.bionexusgenelab.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YDES8.84N/A
N/A
YD Bio Limited
NVR7287.38-13.83
-0.19%
NVR
CTOR1.34-0.03
-2.19%
Citius Oncology Inc
USAC23.13-0.87
-3.63%
USA Compression Partners LP
GLXG3.93-0.18
-4.38%
Galaxy Payroll Group Limited

BGLC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BGLC has been loosely correlated with ECL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BGLC jumps, then ECL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLC
1D Price
Change %
BGLC100%
-6.02%
ECL - BGLC
33%
Loosely correlated
-0.38%
AVTR - BGLC
16%
Poorly correlated
+0.43%
ADKIL - BGLC
11%
Poorly correlated
N/A
ALTO - BGLC
10%
Poorly correlated
+7.02%
AVNT - BGLC
9%
Poorly correlated
-1.17%
More